Indefinite Delivery Contract 75D30122D14203
Award Date
8/1/22
Last Date to Order
7/31/27
Federal Agency
CDC Pittsburgh
Awardee
Pfizer Inc.
Ultimate Awardee
Not listed
NAICS Category
493120 - Refrigerated Warehousing and Storage
PSC Category
R799 - Support- Management: Other
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a single award Indefinite Delivery Contract (IDC) to Glaxosmithkline, LLC for vaccine storage and rotation services. The $3 million, 5-year contract covers the period from August 2023 through August 2028. No set-aside was used. Under the IDC, the CDC issued a $2.8 million firm fixed price delivery order for Glaxosmithkline to provide vaccine storage and rotation support from its facility in...
The Centers for Disease Control and Prevention awarded a single-award, indefinite delivery contract to Sanofi Pasteur Inc. with a potential value of $13 million to provide vaccine storage and rotation services from December 2021 through November 2026. Under the initial firm fixed price delivery order valued at $1.8 million, Sanofi Pasteur will store and manage approximately 6.7 million doses of various pediatric vaccines at its Swiftwater, Pennsylvania facility in support of CDC programs. The...
The Centers for Disease Control and Prevention awarded an indefinite delivery contract to Merck Sharp & Dohme LLC for vaccine storage and rotation services. As the prime contractor, Merck will provide storage and rotation support for CDC immunization programs through September 2026 under a $13 million ceiling. A $6.5 million firm fixed price delivery order was issued to Merck for performance at its Rahway, New Jersey facilities. No set asides or subcontractors were specified. The delivery...
The provided information describes an Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a leading global pharmaceutical corporation. The $425.5 million IDC, with a period of performance running from June 2023 to June 2024, is for the procurement of adult COVID-19 vaccines. As a major supplier of pharmaceutical products and vaccines to the U.S. federal government, Pfizer holds several significant Indefinite Delivery Vehicles (IDVs),...
Pfizer Inc. is providing adult vaccines to the Centers for Disease Control and Prevention under a multiple award indefinite delivery contract. The contract was awarded on July 1, 2020 with a potential value of $48.8 million. Pfizer will supply vaccines for hepatitis A & B, pneumococcal disease, tetanus, diphtheria, herpes zoster, pertussis, measles, mumps, rubella, meningitis, human papillomavirus, varicella, and serogroup B meningococcal disease. Delivery will support immunization...
The Centers for Disease Control and Prevention (CDC) has awarded Pfizer Inc. an Indefinite Delivery Contract (IDC) for the supply of various adult vaccines to support immunization programs under Section 317(j) of the Public Health Service Act. The $103,060,230.33 contract, which runs from July 1, 2023 to June 30, 2024, covers a range of vaccines including hepatitis A, hepatitis B, pneumococcal polysaccharide, tetanus and diphtheria toxoids, herpes zoster, measles-mumps-rubella, meningococcal...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Pfizer Inc., a large pharmaceutical manufacturer, on June 1, 2025. The $458,750,000 multiple-award contract has an ultimate completion date of May 31, 2026 and is for the procurement of adult COVID-19 vaccines. As a prime contractor, Pfizer will be responsible for supplying the CDC's Pittsburgh location with the necessary COVID-19 vaccine products over the...
This federal contract IDV award is a multiple-award Indefinite Delivery Contract between the Centers for Disease Control and Prevention (CDC) and Pfizer Inc., a global pharmaceutical manufacturer. The $117,849,500 contract, with a performance period ending June 30, 2026, is for the delivery of adult vaccines under the CDC's VACCINES program. As the prime contractor, Pfizer will provide a range of pharmaceutical products to multiple federal healthcare agencies, including the Department of...
This Indefinite Delivery Contract (IDC) with a ceiling value of $347,200,000.00 was awarded to Pfizer Inc. on June 1, 2024 by the Centers for Disease Control and Prevention (CDC) to provide COVID-19 adult vaccines. The contract has a period of performance through September 30, 2025 and was awarded without any set-aside designation, reflecting Pfizer's status as a large pharmaceutical corporation. Under this IDC, Pfizer will supply a variety of adult vaccines to support the CDC's public health...
The federal contract IDV award is a $2,208,581,100 Indefinite Delivery Contract issued by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc. for the Vaccines for Children (VFC) program. The contract will provide standard commercial pediatric vaccines to support immunization efforts for eligible children, including those who are Medicaid-eligible, uninsured, American Indian/Alaska Native, or have insurance that does not cover vaccines. Pfizer, as a large pharmaceutical...